C9 Antikörper (Internal Region)
-
- Target Alle C9 Antikörper anzeigen
- C9 (Complement Component C9 (C9))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser C9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Spezifität
- Human C9
- Homologie
- Percent identity by BLAST analysis:
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Recombinant fragment corresponding to a region within amino acids 153 and 429 of C9 (SwissProt P02748). Percent identity by BLAST analysis:
Type of Immunogen: Recombinant protein - Isotyp
- IgG
- Top Product
- Discover our top product C9 Primärantikörper
-
anti-Complement Component C9 (C9) (AA 191-220), (Center) antibody
C9 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB33918 unconjugated
anti-Complement Component C9 (C9) (AA 22-265) antibodyC9 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 136-512) antibodyC9 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 139-519) antibodyC9 Reaktivität: Kaninchen WB, IHC, IP, ICC Wirt: Meerschweinchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 191-220) antibodyC9 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 336-554) antibodyC9 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 205-216) antibodyVerified C9 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-Complement Component C9 (C9) (AA 184-411) antibodyC9 Reaktivität: Human WB, ICC, IHC (p), IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Approved: IHC, IHC-P (1:100 - 1:1000), WB (1:500 - 1:3000)
Usage: Suggested starting dilutions are as follows: Western blot: 1:500-1:3000, IHC-Paraffin: 1:100-1:1000 [suggested antigen retrieval using heat mediated 10 mM Citrate buffer ( pH 6.0) or Tris-EDTA buffer ( pH 8.0)]. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7, 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.
-
- Target
- C9 (Complement Component C9 (C9))
- Andere Bezeichnung
- Complement C9 (C9 Produkte)
- Synonyme
- LOC100037951 antikoerper, LOC100136130 antikoerper, c9 antikoerper, wu:fb60b05 antikoerper, wu:fd50e04 antikoerper, zgc:112272 antikoerper, complement C9 antikoerper, complement component 9 antikoerper, complement component 9 L homeolog antikoerper, C9 antikoerper, c9 antikoerper, c9.L antikoerper
- Hintergrund
-
Name/Gene ID: C9
Subfamily: Complement Component
Synonyms: C9, Complement C9, Complement component 9, Complement component C9 - Gen-ID
- 735
- UniProt
- P02748
- Pathways
- Komplementsystem
-
